The Current and Promising Oral Delivery Methods for Protein- and Peptide-Based Drugs

被引:11
|
作者
Nicze, Michal [1 ]
Borowka, Maciej [1 ]
Dec, Adrianna [1 ]
Niemiec, Aleksandra [1 ]
Buldak, Lukasz [1 ]
Okopien, Boguslaw [1 ]
机构
[1] Med Univ Silesia, Fac Med Sci, Dept Internal Med & Clin Pharmacol, Medykow 18, PL-40752 Katowice, Poland
关键词
peptide- and protein-based drug; oral drug absorption; permeation enhancers; hydrogels; microneedles; semaglutide; octreotide; desmopressin; cyclosporine; CELL-PENETRATING PEPTIDES; CYCLOSPORINE-A; IN-VITRO; CARDIOVASCULAR OUTCOMES; GASTROINTESTINAL MUCUS; INTESTINAL-ABSORPTION; TRYPSIN-INHIBITOR; TIGHT JUNCTIONS; HUMAN INSULIN; NANOPARTICLES;
D O I
10.3390/ijms25020815
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drugs based on peptides and proteins (PPs) have been widely used in medicine, beginning with insulin therapy in patients with diabetes mellitus over a century ago. Although the oral route of drug administration is the preferred one by the vast majority of patients and improves compliance, medications of this kind due to their specific chemical structure are typically delivered parenterally, which ensures optimal bioavailability. In order to overcome issues connected with oral absorption of PPs such as their instability depending on digestive enzymes and pH changes in the gastrointestinal (GI) system on the one hand, but also their limited permeability across physiological barriers (mucus and epithelium) on the other hand, scientists have been strenuously searching for novel delivery methods enabling peptide and protein drugs (PPDs) to be administered enterally. These include utilization of different nanoparticles, transport channels, substances enhancing permeation, chemical modifications, hydrogels, microneedles, microemulsion, proteolytic enzyme inhibitors, and cell-penetrating peptides, all of which are extensively discussed in this review. Furthermore, this article highlights oral PP therapeutics both previously used in therapy and currently available on the medical market.
引用
收藏
页数:29
相关论文
共 50 条
  • [11] Recent Progress of Peptide-based Drug Delivery System
    Li, Yi-jing
    Gong, Xue-feng
    Wang, Dong
    Yang, Zhou
    Cao, Hui
    Wang, Lei
    ACTA POLYMERICA SINICA, 2022, 53 (05): : 445 - 456
  • [12] Peptide-Based Drug Delivery Systems
    Berillo, Dmitriy
    Yeskendir, Adilkhan
    Zharkinbekov, Zharylkasyn
    Raziyeva, Kamila
    Saparov, Arman
    MEDICINA-LITHUANIA, 2021, 57 (11):
  • [13] Herbal Bioenhancers with Nanocarriers: A Promising Approach for Oral Peptide Delivery
    Raghunath, Indu
    Koland, Marina
    Vadakkepushpakath, Anoop Narayanan
    Kumar, Lalit
    Shenoy, Sarathchandran Chandra Shekhar
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2023, 13 (01) : 7 - 13
  • [14] Protein and Peptide-Based Nanotechnology for Enhancing Stability, Bioactivity, and Delivery of Anthocyanins
    Zhang, Lei
    Yao, Liang
    Zhao, Feng
    Yu, Alice
    Zhou, Yueru
    Wen, Qingmei
    Wang, Jun
    Zheng, Tao
    Chen, Pu
    ADVANCED HEALTHCARE MATERIALS, 2023, 12 (25)
  • [15] Oral delivery of therapeutic protein/peptide for diabetes - Future perspectives
    Rekha, M. R.
    Sharma, Chandra P.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 440 (01) : 48 - 62
  • [16] Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress
    Sun, Zhe
    Huang, Jinhai
    Fishelson, Zvi
    Wang, Chenhui
    Zhang, Sihe
    BIOMEDICINES, 2023, 11 (07)
  • [17] The synthesis and characterization of lipophilic peptide-based carriers for gene delivery
    Coles, Daniel J.
    Esposito, Anna
    Chuah, Hui Ting
    Toth, Istvan
    TETRAHEDRON, 2010, 66 (29) : 5435 - 5441
  • [18] Engineering biodegradable and multifunctional peptide-based polymers for gene delivery
    Shi, Julie
    Schellinger, Joan G.
    Pun, Suzie H.
    JOURNAL OF BIOLOGICAL ENGINEERING, 2013, 7 (01):
  • [19] Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs
    Araujo, Francisca
    Shrestha, Neha
    Shahbazi, Mohammad-Ali
    Liu, Dongfei
    Herranz-Blanco, Barbara
    Makila, Ermei M.
    Salonen, Jarno J.
    Hirvonen, Jouni T.
    Granja, Pedro L.
    Sarmento, Bruno
    Santos, Helder A.
    ACS NANO, 2015, 9 (08) : 8291 - 8302
  • [20] Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides
    Mulder, Kelly C. L.
    Lima, Loiane A.
    Miranda, Vivian J.
    Dias, Simoni C.
    Franco, Octavio L.
    FRONTIERS IN MICROBIOLOGY, 2013, 4